STAT4 in Multiple Sclerosis by PCR and Flow Cytometry
NCT03893344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104
Last updated 2020-06-09
Summary
1. To determine the level of STAT4 expression in different cases of multiple sclerosis and its relation to disease severity .
2. compare the sensitivity and specificity of STAT4 levels using both PCR and flow cytometry.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
detection of STAT4 gene
Individuals within both groups will be subjected to STAT4 gene polymorphism typing using both PCR and flow cytometry from a peripheral blood sample
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Ahmed K Mostafa, Professor · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-09-20
- Primary Completion
- 2020-05-20
- Completion
- 2020-05-22
Countries
- Egypt
Study Locations
More Related Trials
-
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
NCT04380220 ·Status: UNKNOWN
-
Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations.
NCT03336424 ·Status: UNKNOWN ·Phase: NA
-
Delayed Diagnosis of Multiple Sclerosis, Treatment Initiation and Non-adherence in Upper Egypt
NCT05438693 ·Status: COMPLETED
-
Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in Egypt
NCT02970370 ·Status: COMPLETED
-
Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis
NCT05451069 ·Status: UNKNOWN
-
Sexual Dysfunction in Patients With Relapsing Remitting Multiple Sclerosis and Associated Comorbidities
NCT04157283 ·Status: UNKNOWN
-
Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)
NCT01883661 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
NCT01881191 ·Status: COMPLETED
-
The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic Syndrome
NCT06256471 ·Status: NOT_YET_RECRUITING
-
Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
NCT02008669 ·Status: COMPLETED
-
Depicting Neurogenic Dysphagia in Multiple Sclerosis Patients; Clinical and Endoscopic Studies
NCT03552185 ·Status: COMPLETED
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED
-
Frequency of Gastrointestinal and Hepatic Manifestations Among Patients with Multiple Sclerosis, a Clinical Hospital Based Study
NCT06770959 ·Status: NOT_YET_RECRUITING
-
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
NCT01188811 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neurofilament Light Chain as Diagnostic and Prognostic Marker in naïve Multiple Sclerosis Patients
NCT06197841 ·Status: ENROLLING_BY_INVITATION
-
Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)
NCT00395317 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis
NCT06599307 ·Status: RECRUITING ·Phase: PHASE2
-
Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation
NCT06957145 ·Status: RECRUITING
-
Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients
NCT02623946 ·Status: COMPLETED
-
Assessment of Quality of Life and Psychological Problems in Patients With Multiple Sclerosis
NCT05029830 ·Status: COMPLETED
-
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
NCT05735067 ·Status: ACTIVE_NOT_RECRUITING
-
Characteristics and Predictors of Progression of an Egyptian Multiple Sclerosis Cohort
NCT03004794 ·Status: COMPLETED
-
Correlation of Serum Lactate and Activity of Multiple Sclerosis
NCT04210960 ·Status: UNKNOWN
-
Photobiomodulation Therapy in Persons With Multiple Sclerosis
NCT03691766 ·Status: COMPLETED ·Phase: NA
-
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
NCT01933802 ·Status: COMPLETED ·Phase: PHASE1